Dr. Mark Rosenblum is a highly acclaimed physician, surgeon, researcher, teacher, and executive. Dr. Rosenblum’s contributions can be witnessed through his development of multiple, nationally recognized healthcare centers and through the books and peer-reviewed articles he has written. As a physician executive he has a special focus on team building and integration, as well as innovation throughout the continuum of healthcare delivery.

Mark L. Rosenblum, MD, currently is Chairman Emeritus of the Department of Neurosurgery in the Henry Ford Health System (HFHS). Originally at UCSF he helped develop their world leading Brain Tumor Research Center, initiated the first brain tumor bank and performed early research on cancer stem cells. In 1984 he founded and for 7 years chaired the Section on Tumors of the AANS and CNS.

During his tenure with HFHS, he founded and served as a co-director of the Hermelin Brain Tumor Center, the HFHS Neurosciences Institute, and the Michigan Spine Surgery Improvement Collaborative. He also was one of 4 leaders who built and helped administer a novel, patient-focused Henry Ford West Bloomfield Hospital where he served as the Vice President of Clinical Programs and the Director of its Center for Healthcare Transformation.

Dr. Rosenblum has served on several hospital and industry boards. He presently is on the Boards of NICO and IZI corporations and is an Adjunct Professor in the Department of Health Management and Policy in the School of Public Health at the University of Michigan. Dr. Rosenblum has particular experience with the value of integrated specialty care, including the development of Centers and Institutes, and developing innovative delivery processes “through the eyes of the patient”.